Skip to Main Content

Paper Details

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
Nat Commun
168
2019
ADAM17, PI3K, PIK3CA mutant, PIK3CA mutant cells, PIK3CB/D, Tumors, cancer, cancer cell lines, molecularly characterized cancer cell lines, patient
Author NameAffiliation
Dennis Wang
Dennis WangSheffield Institute for Translational Neuroscience, University of Sheffield
Yuanfang GuanUniversity of Michigan ann arbor
Thomas Yu
Jaewoo KangKorea University
Minji JeonKorea University
Minji JeonKorea University
In Sock Jang
Mehmet Eren AhsenIBM Thomas J. Watson Research Center
Elias Chaibub Neto
Thea Norman
Mathew J GarnettWellcome Trust Sanger Institute
Stephen Fawell
Gustavo StolovitzkyIBM Thomas J. Watson Research Center
Gustavo StolovitzkyIcahn School of Medicine at Mount Sinai
Gustavo StolovitzkyIBM Thomas J. Watson Research Center
Gustavo StolovitzkyIcahn School of Medicine at Mount Sinai
Justin Guinney
Justin Guinney
Jonathan R Dry
Julio Saez-RodriguezEuropean Bioinformatics Institute
Julio Saez-RodriguezRWTH Aachen University, Joint Research Center for Computational Biomedicine
Julio Saez-RodriguezHeidelberg University, Institute for Computational Biomedicine
  • 1 - 23

Datasets

Release 1.2